Published in Ann Intern Med on May 16, 2006
Giant osteoclast formation and long-term oral bisphosphonate therapy. N Engl J Med (2009) 4.39
Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer. J Clin Oncol (2007) 3.65
Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN. J Dent Res (2011) 3.01
Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc (2008) 2.66
Absence of exposed bone following dental extraction in beagle dogs treated with 9 months of high-dose zoledronic acid combined with dexamethasone. J Oral Maxillofac Surg (2013) 2.58
Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res (2008) 2.42
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract (2011) 2.29
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant (2011) 2.11
NCCN Task Force Report: Bone Health in Cancer Care. J Natl Compr Canc Netw (2009) 1.97
Factors associated with osteonecrosis of the jaw among bisphosphonate users. Am J Med (2008) 1.85
Fracture risk remains reduced one year after discontinuation of risedronate. Osteoporos Int (2007) 1.79
Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis. J Bone Miner Res (2012) 1.73
Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity. J Clin Endocrinol Metab (2013) 1.69
A systematic review of bisphosphonate osteonecrosis (BON) in cancer. Support Care Cancer (2010) 1.68
Osteonecrosis of the jaw after treatment with bisphosphonates: is irreversible, so the focus must be on prevention. BMJ (2006) 1.67
Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer. J Clin Oncol (2010) 1.65
Osteonecrosis of the jaw in a patient on Denosumab. J Oral Maxillofac Surg (2010) 1.59
The management of painful bone metastases with an emphasis on radionuclide therapy. J Natl Med Assoc (2007) 1.55
Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int (2011) 1.50
Atrial fibrillation and stroke associated with intravenous bisphosphonate therapy in older patients with cancer. J Clin Oncol (2010) 1.48
Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice. J Bone Miner Res (2010) 1.41
Bisphosphonates cause osteonecrosis of the jaw-like disease in mice. Am J Pathol (2010) 1.40
Adverse effects of bisphosphonates: implications for osteoporosis management. Mayo Clin Proc (2009) 1.39
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int (2012) 1.36
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Transplant (2012) 1.28
Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment. J Oral Maxillofac Surg (2008) 1.27
Cathepsin K inhibitors for osteoporosis and potential off-target effects. Expert Opin Investig Drugs (2009) 1.26
Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases. J Cancer Res Clin Oncol (2010) 1.26
Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs. J Bone Miner Res (2010) 1.25
Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents. Cancer Invest (2009) 1.23
Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats. J Bone Miner Res (2010) 1.23
Potential pathophysiological mechanisms in osteonecrosis of the jaw. Ann N Y Acad Sci (2011) 1.22
Treatment of breast cancer with bone metastasis: bisphosphonate treatment - current and future. Int J Clin Oncol (2008) 1.21
Clinical development of anti-RANKL therapy. Arthritis Res Ther (2007) 1.17
Skeletal complications of breast cancer therapies. Clin Cancer Res (2006) 1.16
Current approach to fibrous dysplasia of bone and McCune-Albright syndrome. J Child Orthop (2007) 1.13
Protocol for the Osteoporosis Choice trial. A pilot randomized trial of a decision aid in primary care practice. Trials (2009) 1.12
Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review. Nat Rev Endocrinol (2010) 1.12
Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis. Ther Clin Risk Manag (2010) 1.12
Disparate osteogenic response of mandible and iliac crest bone marrow stromal cells to pamidronate. Oral Dis (2008) 1.10
Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up. Support Care Cancer (2009) 1.08
Guidelines for the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ). Clin Cases Miner Bone Metab (2007) 1.06
Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs. Osteoporos Int (2010) 1.06
Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis. Br J Haematol (2008) 1.06
Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection. J Clin Invest (2011) 1.05
ONJ in two dental practice-based research network regions. J Dent Res (2011) 1.04
Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study. Clin Oral Investig (2009) 1.03
Post-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions. Br J Clin Pharmacol (2008) 1.01
Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker. Osteoporos Int (2008) 0.99
Management of cancer treatment-induced bone loss in early breast and prostate cancer -- a consensus paper of the Belgian Bone Club. Osteoporos Int (2007) 0.99
Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients. Osteoporos Int (2010) 0.99
Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws. J Cancer Res Clin Oncol (2010) 0.99
Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients. Clin Interv Aging (2012) 0.98
Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid. J Bone Miner Metab (2009) 0.98
Osteonecrosis of jaw associated with bisphosphonate use. Indian J Endocrinol Metab (2012) 0.97
Bisphosphonates-related osteonecrosis of the jaw in Korea: a preliminary report. J Korean Assoc Oral Maxillofac Surg (2013) 0.96
Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist (2011) 0.95
Bevacizumab-associated osteonecrosis of the jaw. Ann Oncol (2008) 0.94
A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures. Osteoporos Int (2013) 0.94
Case series of 589 tooth extractions in patients under bisphosphonates therapy. Proposal of a clinical protocol supported by Nd:YAG low-level laser therapy. Med Oral Patol Oral Cir Bucal (2013) 0.92
The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK. Osteoporos Int (2009) 0.91
Osteoporosis prevention and therapy: preserving and building strength through bone quality. Osteoporos Int (2006) 0.91
Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role. Arthritis Res Ther (2006) 0.90
Bisphosphonate-associated osteonecrosis of the jaw: what do we currently know? A survey of knowledge given in the recent literature. Clin Oral Investig (2009) 0.90
Phosphate: known and potential roles during development and regeneration of teeth and supporting structures. Birth Defects Res C Embryo Today (2008) 0.90
Intravenous bisphosphonates for postmenopausal osteoporosis. J Res Med Sci (2010) 0.90
Diagnosis and management of osteoporosis in the older senior. Clin Interv Aging (2009) 0.90
Teriparatide - Indications beyond osteoporosis. Indian J Endocrinol Metab (2012) 0.89
Oral bisphosphonate-associated osteonecrosis of maxillary bone: A review of 18 cases. J Clin Exp Dent (2014) 0.89
Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: summary. J Bone Miner Metab (2013) 0.89
Bisphosphonate induced osteonecrosis of jaw in breast cancer patients: A systematic review. J Oral Maxillofac Pathol (2012) 0.89
Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report. Spec Care Dentist (2010) 0.89
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations. Endocr Pract (2011) 0.88
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2006) 0.88
Oral bisphosphonate-related osteonecrosis of the jaw: the first report in Asia. Osteoporos Int (2009) 0.88
Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary. Clin Interv Aging (2010) 0.88
Breast Cancer: Rank Ligand Inhibition. Breast Care (Basel) (2010) 0.88
Osteoporosis in juvenile idiopathic arthritis--a practical approach to diagnosis and therapy. Eur J Pediatr (2007) 0.88
Anatomic site variability in rat skeletal uptake and desorption of fluorescently labeled bisphosphonate. Oral Dis (2010) 0.87
Tooth extraction in osteoporotic patients taking oral bisphosphonates. Osteoporos Int (2013) 0.87
Bisphosphonate-related osteonecrosis of the jaws: an update on clinical, pathological and management aspects. Head Neck Pathol (2007) 0.87
Skeletal complications of bisphosphonate use: what the radiologist should know. Br J Radiol (2012) 0.87
Legal liability in bisphosphonate-related osteonecrosis of the jaw. Br Dent J (2014) 0.87
The collection of NFATc1-dependent transcripts in the osteoclast includes numerous genes non-essential to physiologic bone resorption. Bone (2012) 0.87
Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery? Lasers Med Sci (2011) 0.86
Ibandronate uptake in the jaw is similar to long bones and vertebrae in the rat. J Bone Miner Metab (2008) 0.86
Estrogen regulation of apoptosis in osteoblasts. Physiol Behav (2009) 0.86
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Hematol Oncol Stem Cell Ther (2012) 0.86
Bisphosphonate-related osteonecrosis of the jaw: clinical correlations with computerized tomography presentation. Clin Oral Investig (2009) 0.86
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Rev Bras Hematol Hemoter (2012) 0.86
A novel soft-tissue in vitro model for bisphosphonate-associated osteonecrosis. Fibrogenesis Tissue Repair (2010) 0.86
A review of denosumab for the treatment of osteoporosis. Patient Prefer Adherence (2014) 0.86
Magnetic resonance imaging of bone marrow in oncology, Part 2. Skeletal Radiol (2007) 0.86
Bisphosphonate use in acute and chronic spinal cord injury: a systematic review. J Spinal Cord Med (2009) 0.86
Osteonecrosis of the jaw--a potential adverse effect of bisphosphonate treatment. Nat Clin Pract Endocrinol Metab (2006) 0.85
A novel bioassay model to determine clinically significant bisphosphonate levels. Support Care Cancer (2009) 0.85
Bisphosphonate-associated osteonecrosis of the mandible: reliable soft tissue reconstruction using a local myofascial flap. Clin Oral Investig (2011) 0.85
Periodontal disease as a risk factor for bisphosphonate-related osteonecrosis of the jaw. J Periodontol (2013) 0.85
Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect. Core Evid (2010) 0.85
Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol (2007) 4.52
Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc (2011) 3.76
Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc (2010) 3.44
Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol (2004) 3.09
Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc (2008) 2.36
Gnathic osteoblastoma: clinicopathologic review of seven cases with long-term follow-up. Oral Oncol (2005) 1.55
A commentary on "Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease" by R.E. Marx and R. Tursun [Int. J. Oral Maxillofac. Surg. 41 (2012) 283-289]. Int J Oral Maxillofac Surg (2012) 1.40
A nodular submental mass. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2007) 1.40
Palatal perforation associated with intranasal prescription narcotic abuse. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2005) 1.34
Aggressive osteoblastoma of the maxilla: a case report and review of the literature. Head Neck Pathol (2010) 1.22
Celiac disease and recurrent aphthous stomatitis: a report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2002) 1.20
Traumatic lesions of the gingiva: a case series. J Periodontol (2004) 1.20
Sclerosing polycystic adenosis of minor salivary glands: report of three cases and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2007) 1.10
Trabecular and psammomatoid juvenile ossifying fibroma of the skull base mimicking psammomatoid meningioma. Head Neck Pathol (2010) 1.10
A comparison of the cleaning efficacy of short-term sonic and ultrasonic passive irrigation after hand instrumentation in molar root canals. J Endod (2003) 1.05
Solitary central myofibroma presenting in the gnathic region. Ann Diagn Pathol (2004) 1.01
Multifocal calcifying epithelial odontogenic tumor. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2006) 1.01
Squamous odontogenic tumor: diagnosis and management. J Periodontol (2002) 0.98
Nerve sheath myxoma (neurothekeoma) of the gingiva, a case report and review of the literature. Head Neck Pathol (2010) 0.92
Verruciform xanthoma: immunohistochemical characterization of xanthoma cell phenotypes. J Periodontol (2007) 0.92
Incidental findings on cone beam computed tomography images. Int J Dent (2012) 0.91
The role of direct visual fluorescent examination (VELscope) in routine screening for potentially malignant oral mucosal lesions. Oral Surg Oral Med Oral Pathol Oral Radiol (2012) 0.88
Allelic imbalance in oral lichen planus and assessment of its classification as a premalignant condition. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2011) 0.88
Gingival cyst of the adult: regenerative therapy of associated root exposure. A case report and literature review. J Periodontol (2009) 0.87
Oral graft-versus-host disease and programmed cell death: pathogenetic and clinical correlates. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2004) 0.84
Zoonotic anatrichosomiasis in an Illinois resident. Am J Trop Med Hyg (2010) 0.83
Lymphomatoid granulomatosis presenting with gingival involvement in an immune competent elderly male. Head Neck Pathol (2012) 0.82
Keratocystic odontogenic tumor: a retrospective analysis of genetic, immunohistochemical and therapeutic features. Proposal of a multicenter clinical survey tool. Oral Surg Oral Med Oral Pathol Oral Radiol (2013) 0.82
Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. Tex Dent J (2012) 0.82
Using resorbable screws for fixation of cortical onlay bone grafts: an in vivo study in rabbits. J Oral Maxillofac Surg (2004) 0.81
Bis-phossy jaw, phossy jaw, and the 21st century: bisphosphonate-associated complications of the jaws. J Oral Maxillofac Surg (2004) 0.80
Pagetoid reticulosis: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2003) 0.80
Post-irradiation leiomyosarcoma of the maxilla: report of a case in a patient with prior radiation treatment for retinoblastoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2004) 0.78
Osteonecrosis of the jaws and bisphosphonates. Alpha Omegan (2007) 0.78
Basal cell carcinoma of the buccal mucosa in a patient with nevoid basal cell carcinoma syndrome. Int J Surg Pathol (2009) 0.78
Oral atypical cellular blue nevus: an infiltrative melanocytic proliferation. Head Neck Pathol (2012) 0.75
Clinical-pathological conference: case 4. Head Neck Pathol (2010) 0.75
Intraoral phaeohyphomycosis. Head Neck Pathol (2012) 0.75
Undifferentiated malignant neoplasm involving the interdental gingiva: a case report. J Periodontol (2004) 0.75
Commentary on proposed new classification system for BRONJ. Oral Dis (2012) 0.75
Presentation of an epithelioid cell histiocytoma on the ventral tongue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2005) 0.75
AAOMP case challenge: "The case of a subtle expansion of the mandible". J Contemp Dent Pract (2002) 0.75
Oral and maxillofacial pathology case of the month. Herniated dental follicle. Tex Dent J (2014) 0.75
AAOMP case challenge: an expansile mass of the right posterior mandible. J Contemp Dent Pract (2006) 0.75
Adjuncts for the evaluation of potentially malignant disorders in the oral cavity: Diagnostic test accuracy systematic review and meta-analysis-a report of the American Dental Association. J Am Dent Assoc (2017) 0.75
Diffuse pigmentation of maxillary attached gingiva: four cases of the cultural practice of gingival tattoo. J Periodontol (2007) 0.75
Oral mucosal melanoma with unusual clinicopathologic features. J Cutan Pathol (2008) 0.75
Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity: A report of the American Dental Association. J Am Dent Assoc (2017) 0.75
AAOMP case challenge: a pigmented lesion of the mandibular facial gingiva. J Contemp Dent Pract (2007) 0.75